Company profile for Benuvia Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Benuvia Therapeutics Inc. is focused on financing and developing low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases. We seek partnerships to support the late-stage development and commercialization of our pipeline. Benuvia markets SYNDROS®, our U.S. Food & Drug Administration-approved cannabinoid drug. Through our affiliate, Benuvia Manufacturing, we operat...
Benuvia Therapeutics Inc. is focused on financing and developing low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases. We seek partnerships to support the late-stage development and commercialization of our pipeline. Benuvia markets SYNDROS®, our U.S. Food & Drug Administration-approved cannabinoid drug. Through our affiliate, Benuvia Manufacturing, we operate a state-of-the-art Research & Development and cGMP manufacturing facility.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
444 South Ellis Street Chandler, AZ 85224
Telephone
Telephone
(480) 581-1385
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/benuvia-operations-signs-commercial-supply-agreement-with-leading-us-pharmaceutical-company-for-dronabinol-api-302453302.html

PR NEWSWIRE
13 May 2025

https://www.prnewswire.com/news-releases/benuvia-operations-llc-and-department-of-veterans-affairs-sign-crada-agreement-302304237.html

PR NEWSWIRE
13 Nov 2024

https://www.prnewswire.com/news-releases/benuvia-appoints-terry-novak-as-new-ceo-302243594.html

PR NEWSWIRE
10 Sep 2024

https://www.accesswire.com/709719/Jupiter-Wellness-Announces-Repayment-Agreement-with-Benuvia-Inc-Formally-Next-Frontier-Pharmaceuticals

ACCESSWIRE
26 Jul 2022

https://www.prnewswire.com/news-releases/benuvia-a-drug-developer-focused-on-pharmaceutical-cannabinoids-and-the-owner-of-fda-approved-syndros-receives-approval-from-the-us-dea-to-manufacture-psychedelic-active-pharmaceutical-ingredients-including-psilocybin-mdma-an-301547601.html

PRNEWSWIRE
16 May 2022

ABOUT THIS PAGE

Contact Benuvia Therapeutics and get a quotation

Benuvia Therapeutics is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Cannabidiol bulk with DMF offered by Benuvia Therapeutics

Find a price of Tetrahydrocannabinol bulk with DMF offered by Benuvia Therapeutics

Find a price of Cannabidiol bulk offered by Benuvia Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty